drugset / Trial / NCT03962920
Personalized Treatment of Urogenital Cancers Depends on the Microbiome
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.
Timeline
- Start
- 2020-05-01
- Primary completion
- 2025-05-01
- Completion
- 2027-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tigecycline | Small molecule | 50 mg | Other |